Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move (CSE:
$AGRA.C) (CSE: $DIXI_U.C) (CSE: $CURA.C) (TSXV: $RPP.V)
Delta, Kelowna, BC –May 30,
2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its potcast
site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and
experts.
Listen to the podcast:
Read this in full
at https://www.investorideas.com/news/2019/cannabis-potcasts/05301AGRA-DIX-CURA-RPP.asp
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com “potcasts”,
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts.
In
today’s podcast we look at a few early announcements.
AgraFlora Organics
International Inc. (CSE: AGRA) (OTC: PUFXF), a growth oriented and diversified
international cannabis company, announced that the Company has applied for licensing
with Health Canada under the Industrial Hemp Regulations of the Cannabis Act.
The
Company anticipates that license approval could be granted in the third quarter
of 2019, which will subsequently equip AgraFlora with the ability to seed,
cultivate and harvest industrial hemp at its flagship 2.2 million square foot
Delta, BC facility.
Upon
successful grant of an Industrial Hemp License, AgraFlora intends to
aggressively pursue proprietary Cannabidiol ("CBD") cultivar
development, as well as: Seedling development; Cultivar experimentation; and
Specialized fibre production.
"We
are thrilled to gain additional exposure to the burgeoning hemp and CBD
marketplaces," said Brandon Boddy, Chairman and CEO of AgraFlora Organics
International Ltd. "The cultivation of hemp is a natural accompaniment to
our overall cannabis strategy, which will bring material synergies to our
existing cultivation operations. By way of our existing cultivation
infrastructure at the Delta Greenhouse Complex, we will continue to leverage
the vast skillset of the Houwelings Group. Furthermore, AgraFlora's Industrial
Hemp License will allow for ample access to low-cost, high-volume raw material
for the extraction of CBD, which has been increasingly recognized for its
therapeutic benefits across a wide range of medical indications and wellness
applications."
Therabis LLC, a leading pet wellness
company and a subsidiary of Dixie Brands
Inc. (CSE: DIXI.U) (OTC: DXBRF), has announced that Vedco, Inc. will begin distributing
its full-spectrum hemp-based, highly-palatable, soft-chew supplements to their
network of distributors who are the leading suppliers to veterinary clinics
across the USA.
Vedco is a logistics, sales and marketing
provider of Animal Health products that is owned by many of the leading
distributors in the US Animal Health Market and it creates a more efficient
procurement infrastructure exclusively focused on servicing the veterinary
channel. With a combined network of 98 distributor locations nationwide, Vedco
is one of the country's largest veterinary suppliers with a client list that
includes more than 30,000 clinics.
"We are pleased to have been selected
by Vedco as the first full-spectrum soft chew hemp supplier that they are
offering to their distribution network," said Bob Rubin, President of
Therabis. "Many pet owners rely on
their veterinarian to recommend a product that best addresses their pet's
specific ailment. We expect that our participation in that channel will help
strengthen our leadership position both among veterinary patients and retail
consumers in general."
Therabis will introduce a series of new
formulations of its products called "Therabis Veterinarian Formula,"
in recognition of the fact that pets requiring veterinary care are more likely
to require stronger versions. These
products will include higher concentrations of cannabinoids and other approved
natural ingredients for more targeted therapeutic value in comparison to the
formulations currently sold through retail and online channels. Therabis
Veterinarian Formula versions will initially be available for the canine
"Mobility" supplement, as well as both the canine and feline versions
of the "Calming" stress relief products. Therabis will soon add other
indication-specific veterinary formulas.
"We are very excited about a
full-spectrum, plant-based nutraceutical derived from hemp in a soft chew
dosage form that veterinary hospitals can offer to their clients for overall
pet wellness," said Craig Campbell, General Manager of Vedco, Inc.
"We have looked closely at Therabis products and we are pleased to
showcase them to our full national distribution network."
Veterinarians are highly influential in recommending
therapeutic products for pet owners. According to Packaged Facts, veterinarians
are the most important source of pet care information for 70% of dog and cat
owners, far surpassing any other source and more than doubling online research.
The American Veterinary Medical Association recognizes nutraceutical therapy as
important as part of their guidelines related to complimentary or alternative
medicine. The nutraceutical market has been estimated by Grand View Research to
exceed $2 billion in the U.S.
Continuing
with Dixie Brands, who also issued a statement about the passage into law of Colorado
bill HB19-1090, a bipartisan bill providing greater investment flexibility in
marijuana businesses.
Dixie
Brands supports the legislation and applauds the Colorado legislature and
Governor Jared Polis for signing it into law. The Company also intends to
explore opportunities to expand investment in Denver-based cannabis operations,
once the law is fully in place.
"This
is a defining moment for Colorado's cannabis industry and a tremendous boost to
Colorado's economy," said Chuck Smith, CEO of Dixie Brands. "By
permitting access to capital through private and public investments with
appropriate guardrails, this bill ensures that Colorado businesses keep their
headquarters in the state, remain competitive, invest in research and development
and other innovation and continue to contribute significant tax dollars to the
state."
Dixie
and other publicly listed companies in Colorado have not been permitted to own
cannabis production or manufacturing operations. Dixie owns the intellectual
property and licensing rights associated with its portfolio of cannabis-infused
products. The THC-infused products are manufactured and distributed in Colorado
by a private state-licensed company controlled by an investor and Board Member
of Dixie Brands. With the passage of HB19-1090, Dixie intends to explore a
transaction to acquire and operate the licensed manufacturer. Any such
transaction would be subject to successfully completing a state licensing
application, as well as review by an independent committee of Dixie's Board.
In
the event a transaction is completed, it would create expanded opportunities
for Dixie to invest in its Colorado production operations as the Company
continues to grow its business. Ownership of the manufacturing operation would
result in increased revenue and gross margin for Dixie.
Chuck
Smith is actively involved in the state's cannabis industry and has worked with
other business leaders for the passage of HB19-1090. He currently sits as Board
President of Colorado Leads, a pro-business alliance of more than 50 Colorado
companies created to help educate the general public about the economic and
community benefits of a safe, regulated medical and recreational cannabis
industry.
Curaleaf Holdings,
Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis
operator in the United States, today announced that it completed the acquisition of the
Emerald dispensary in Gilbert, Arizona, whose license is held by Absolute Healthcare,
Inc., an Arizona non-profit corporation. The signing was announced earlier on
May 21, 2019 and the transaction was closed on May 29, 2019. The dispensary is
expected to be rebranded as Curaleaf over the next month.
Emerald
is the only dispensary licensed to operate in the Town of Gilbert which is
located in the Metro Phoenix area. It is one of Arizona's largest and longest
standing medical cannabis retailers, serving over 44,000 unique patients since
2014.
Curaleaf
has the largest footprint of single-branded retail stores in the U.S. and is
executing on its strategy of building a national brand in highly populated
states. Curaleaf will continue to explore opportunities to open additional
locations throughout the state of Arizona in 2019.
Regent Pacific
Group Limited (HK: 00575) (TSX-V: RPP), a specialist healthcare, wellness and
life sciences investment group, has signed an indicative non-legally binding offer
letter with Entertainment Direct Asia Ltd. to acquire Yooya for a potential consideration of US$15 million. If
successful, the transaction would be effected through a share for share
exchange.
Following
the transaction, Yooya will expand its sector focus and become the first e-commerce
marketing platform to focus on CBD infused products that are designed to awaken
the body's natural healing system and promote better health and sleep; and
products that safely eliminate the psychoactive THC from hemp.
Yooya
is a content-driven e-commerce platform that is reshaping the way that brands
connect with Chinese consumers. Total e-commerce revenue in China is forecast
to top US$1.8 trillion by 2022. Yooya recognises that the way that Chinese
consumers shop and the factors that influence purchase decisions have changed
dramatically, with video content consumption being the single most popular
activity on the internet in China. Japan, Asia's second largest e-commerce
market in dollar terms, will see nearly 90 million e-commerce shoppers by 2021.
Yooya
helps brands to reach the right audiences through its targeted video platform;
and substantial network of content producers and e-commerce providers. John
Possman and Richard Myers, existing directors of Yooya, have over fifty years
of experience combined in media, technology, and consumer products in Greater
China, Japan, and other markets in Asia.
Yooya
is particularly focused on brands in the beauty and cosmetics, health and
wellness, apparel, and related sectors. Recent research from Kantar shows that
in 2018 annual online sale of cosmetics, skincare, and personal-care products
in China grew by 46%, 40% and 37% respectively.
Jamie Gibson, Chief
Executive Officer of Regent Pacific,
said, "We see huge opportunity to use the Yooya team's extensive
experience in digital marketing and partnerships with both influencers and
e-commerce platforms to support the roll out of our CBD, organics and natural
formulations business, which require more targeted engagement to reach the
end-consumer."
The
possible acquisition remains subject to a number of pre-conditions, including
completion of due diligence, respective approvals of the Company's and Yooya's
boards and formal acquisition documentation to be agreed between the Company
and each of Yooya's shareholders.
To
further support the expansion into new product lines, the Company has also
signed subscription agreements with Jim Mellon, Jamie Gibson and an experienced
group of strategic investors including principals of JJR Capital and Abony
Enterprises in CBD, organics and natural formulations for a total amount of
approximately US$17.5 million in convertible loan notes.
"The
capital raised through this offering will help us drive our rapid expansion
into the fast-growing CBD segment, which is estimated to be worth up to US$15
billion in China alone by 2024, added Jamie
Gibson. "We envisage rolling out our CBD business in Asia with a line
of exceptional consumer-focused products initially in the health and wellness
area, including topicals and balms, and working with the world's largest CBD
manufacturers to build out our CBD brands over time. The participants in this
offering include strategic investors in the Company who have generated very
successful investment returns in the CBD market and we are grateful for their
confidence in the Company."
Investor ideas reminds all listeners to read our disclaimers and
disclosures on the
Investorideas.com website and this podcast is not an endorsement
to buy products or services or securities. Investors are reminded all
investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available
on iTunes, Spotify, Google Play Music,
Stitcher, Spreaker, YouTube via
Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark
on the blockchain through Cognate, Inc. CM Certification-Registration Number:
10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news
source publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play
by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the AI
Eye Podcast and column covering developments in
AI.
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ and
tickertagstocknews.com
Global investors must adhere to regulations of each
country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use
of cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
